Publication
Risk and management of patients with cancer and heart disease
| dc.contributor.author | Hill, Loreena | |
| dc.contributor.author | Delgado, Bruno | |
| dc.contributor.author | Lambrinou, Ekaterini | |
| dc.contributor.author | Mannion, Tara | |
| dc.contributor.author | Harbinson, Mark | |
| dc.contributor.author | McCune, Claire | |
| dc.date.accessioned | 2023-02-24T15:59:50Z | |
| dc.date.available | 2023-02-24T15:59:50Z | |
| dc.date.issued | 2023-06-01 | |
| dc.description.abstract | Cancer and cardiovascular disease are two of the leading causes of global mortality and morbidity. Medical research has generated powerful lifesaving treatments for patients with cancer; however, such treatments may sometimes be at the expense of the patient’s myocardium, leading to heart failure. Anti-cancer drugs, including anthracyclines, can result in deleterious cardiac effects, significantly impacting patients’ functional capacity, mental well-being, and quality of life. Recognizing this, recent international guidelines and expert papers published recommendations on risk stratification and care delivery, including that of cardio-oncology services. This review will summarize key evidence with a focus on anthracycline therapy, providing clinical guidance for the non-oncology professional caring for a patient with cancer and heart failure. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.doi | 10.1007/s40119-023-00305-w | pt_PT |
| dc.identifier.eid | 85147769444 | |
| dc.identifier.issn | 2193-8261 | |
| dc.identifier.pmid | 36757637 | |
| dc.identifier.uri | http://hdl.handle.net/10400.14/40361 | |
| dc.identifier.wos | 000931762800001 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | pt_PT |
| dc.subject | Anthracycline | pt_PT |
| dc.subject | Cardiotoxicity | pt_PT |
| dc.subject | Heart failure | pt_PT |
| dc.subject | Risk stratification | pt_PT |
| dc.title | Risk and management of patients with cancer and heart disease | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 241 | |
| oaire.citation.issue | 2 | |
| oaire.citation.startPage | 227 | |
| oaire.citation.title | Cardiology and Therapy | pt_PT |
| oaire.citation.volume | 12 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |